HomeTNDM • NASDAQ
add
Tandem Diabetes Care Inc
Previous close
$36.00
Day range
$34.51 - $35.93
Year range
$21.86 - $53.69
Market cap
2.33B USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 243.97M | 31.43% |
Operating expense | 150.75M | 24.28% |
Net income | -23.25M | 29.46% |
Net profit margin | -9.53 | 46.34% |
Earnings per share | -0.36 | 5.06% |
EBITDA | -21.88M | 20.49% |
Effective tax rate | -2.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 473.30M | -4.99% |
Total assets | 957.73M | 1.90% |
Total liabilities | 720.02M | 15.04% |
Total equity | 237.71M | — |
Shares outstanding | 65.68M | — |
Price to book | 9.94 | — |
Return on assets | -6.88% | — |
Return on capital | -9.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.25M | 29.46% |
Cash from operations | 26.78M | 48,589.09% |
Cash from investing | -19.90M | 59.00% |
Cash from financing | -4.52M | -136.47% |
Net change in cash | 1.34M | 102.62% |
Free cash flow | 28.09M | 301.80% |
About
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. Wikipedia
Founded
2006
Website
Employees
2,400
